IP Library Granted Patent US 10,654,041
Granted Patent B2
US 10,654,041 · App. 14/210,127 · Granted May 19, 2020

Reagent wells containing lyophilized reagents

Inventor: Byron J. Knight (San Diego, CA)
Assignee: Gen-Probe Incorporated
B01L3/5085B01L3/502B01L3/5082B01L3/50825B01L3/50853B01L3/50855B01L3/523B01L3/527B65B69/00B65D1/0207B65D1/34B65D1/36B65D17/50B65D39/0017B65D39/0029C12Q1/686G01N35/0099G01N35/026G01N35/10G01N35/1002G01N35/1079B01L2200/02B01L2200/025B01L2200/026B01L2200/0668B01L2200/0689B01L2200/141B01L2200/142B01L2200/16B01L2300/042B01L2300/044B01L2300/046B01L2300/047B01L2300/048B01L2300/0609B01L2300/0829B01L2300/0832B01L2300/0838B01L2300/0851B01L2300/0858B01L2300/12B01L2400/0406B65D2539/003G01N30/6091G01N2035/00287Y10T436/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,654,041
App. No.
14/210,127
Granted
May 19, 2020
Kind
B2
Abstract

System, apparatuses, and methods for performing automated reagent-based analysis are provided. Also provided are methods for automated attachment of a cap to a reaction receptacle, and automated removal of a cap from a capped reaction receptacle.

Claims (16)

1. A reagent well comprising:

a side wall, a bottom wall, and an open upper end defined by a top surface;

a lyophilized reagent disposed within the reagent well; and

a plurality of retention features that are integral with a side wall of the reagent well, the retention features being positioned entirely above the lyophilized reagent and extending inwardly from the side wall, and the retention features defining an opening sized to retain the lyophilized reagent within the reagent well and to permit an end of a pipette tip to be inserted into the well, wherein the retention features comprise a set of longitudinally extending and circumferentially-spaced rigid guides projecting radially from the side wall.

2. The reagent well of claim 1 , wherein the lyophilized reagent is retained within the reagent well at, or adjacent to, the bottom wall.

3. The reagent well of claim 1 , wherein the reagent well includes one or more features formed in the bottom wall to facilitate the deposit of a fluid into the reagent well and/or the collection of a fluid from the reagent well.

4. The reagent well of claim 3 , wherein the one or more features formed in the bottom wall are located at the axial center of the reagent well.

5. The reagent well of claim 3 , wherein the one or more features formed in the bottom wall include one or more grooves.

6. The reagent well of claim 5 , wherein the one or more grooves consist of a pair of crisscrossed grooves.

7. The reagent well of claim 3 , wherein the one or more features formed in the bottom wall include one or more ridges.

8. The reagent well of claim 7 , wherein the one or more ridges consist of a pair of crisscrossed ridges.

9. The reagent well of claim 8 , wherein the one or more ridges consist of an annular ridge.

10. The reagent well of claim 3 , wherein the one or more features formed in the bottom wall include a plurality of bumps.

11. The reagent well of claim 1 further including a frangible seal affixed to the top surface and covering the open upper end.

12. The reagent well of claim 1 , wherein the retention features consist of from 2 to 8 of the rigid guides.

13. The reagent well of claim 1 , wherein the side wall is tapered.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 032753/0942 Recorded Jun 3, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035813/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: KNIGHT, BYRON J.
To: GEN-PROBE INCORPORATED
Reel/Frame 032958/0817 →
SECURITY INTEREST Recorded Apr 25, 2014
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK, USA
Reel/Frame 032753/0942 →
Continuity (2)
Provisional Application 61782320 · Mar 14, 2013
Related Publication 20140272989A1 · Sep 18, 2014